| 注册
首页|期刊导航|天津中医药|扶正透邪解毒方调控NLRP3/Caspase-1/GSDMD通路治疗多重耐药菌感染肺炎的药效与作用机制

扶正透邪解毒方调控NLRP3/Caspase-1/GSDMD通路治疗多重耐药菌感染肺炎的药效与作用机制

刘艳彬 朱睿 吴彩军 晏军

天津中医药2026,Vol.43Issue(8):1017-1027,11.
天津中医药2026,Vol.43Issue(8):1017-1027,11.DOI:10.11656/j.issn.1672-1519.2026.08.10

扶正透邪解毒方调控NLRP3/Caspase-1/GSDMD通路治疗多重耐药菌感染肺炎的药效与作用机制

Efficacy and mechanism of action of Fuzheng Touxie Jiedu Prescription in modulating NLRP3/Caspase-1/GSDMD pathways in rats with pneumonia caused by multi-drug resistant organisms

刘艳彬 1朱睿 2吴彩军 3晏军4

作者信息

  • 1. 北京中医药大学东直门医院,北京 100700
  • 2. 清华大学玉泉医院,北京 100040
  • 3. 北京中医药大学东直门医院,北京 100700||北京中医药大学脓毒症研究所,北京 100700
  • 4. 北京中医药大学第三附属医院,北京 100029||北京中医药大学脓毒症研究所,北京 100700
  • 折叠

摘要

Abstract

[Objective]To explore the pharmacodynamic effects and mechanisms of Fuzheng Touxie Jiedu Prescription on rats with pneumonia caused by multi-drug resistant organisms based on liquid chromatography-quadrupole-time of flight mass spectrometry(LC-Q-TOF-MS),network pharmacology,molecular docking,and animal experiments.[Methods]A rat model of pneumonia caused by multi-drug resistant Pseudomonas aeruginosa was established via tracheal instillation.Thirty rats were randomly divided into 5 groups:blank control group,model group,traditional Chinese medicine(TCM)group(Fuzheng Touxie Jiedu Prescription),Western medicine group,and integrated Chinese-Western medicine group.Additionally,another 6 rats were divided into the normal group and the drug-administered group for the preparation of drug-containing serum.LC-Q-TOF-MS was used for chemical analysis of drug-containing serum.Network pharmacology predicted the active components,core targets,and signaling pathways of the prescription.Molecular docking was performed using the CB-Dock2 platform.Hematoxylin and eosin(HE)staining assessed lung tissue pathology.ELISA was used to detect the expression olevels of interleukin(IL)-18,IL-1β,tumor necrosis factor(TNF)-α,and IL-6 in rat serum.Quantitative real-time PCR(qPCR)and Western blot measured mRNA and protein expression levels of nucleotide-binding oligomerization domain-like receptor protein 3(NLRP3),apoptosis-associated speck-like protein(ASC),Caspase-1,and gasdermin D(GSDMD)in rat lung tissue.[Results]Thirty-four active components were identified.Analysis revealed 176 intersecting targets related to both the disease and the prescription,including 38 core targets(NFKB1,TNF,IL6,AKT1,etc.).Core active components included 7-Hydroxycoumarin,Salvianono,Quercetin,Liquiritin,etc.Key signaling pathway involved MAPK,PI3K-Akt,FoxO signaling pathways,primaily related to inflammation and immunity.Molecular docking demonstrated strong binding activity between key components and core targets.Animal experiments showed that the Fuzheng Touxie Jiedu Prescription alleviated pathological lung tissue damage,and inhibited the expressions of inflammatory factors including IL-18,IL-1β,TNF-α,and IL-6 in serum,downregulated mRNA and protein expression of NLRP3,ASC,Caspase-1,and GSDMD in lung tissue.[Conclusion]The Fuzheng Touxie Jiedu Prescription exhibits therapeutic effects against multi-drug resistant organisms pneumonia in rats.Its mechanisms likely involves regulating the NLRP3/Caspase-1/GSDMD signaling pathway to inhibit excessive inflammation and immune responses.

关键词

多重耐药菌感染肺炎/扶正透邪解毒方/NLRP3/Caspase-1/GSDMD信号通路/液相色谱-四极杆-飞行时间质谱/网络药理学

Key words

pneumonia caused by multi-drug resistant organisms/Fuzheng Touxie Jiedu Prescription/NLRP3/Caspase-1/GSDMD signaling pathway/LC-Q-TOF-MS/network pharmacology

分类

医药卫生

引用本文复制引用

刘艳彬,朱睿,吴彩军,晏军..扶正透邪解毒方调控NLRP3/Caspase-1/GSDMD通路治疗多重耐药菌感染肺炎的药效与作用机制[J].天津中医药,2026,43(8):1017-1027,11.

基金项目

中华中医药学会求实项目(2024-QNQS-06) (2024-QNQS-06)

北京中医药大学2025年基本科研业务费"揭榜挂帅"项目(2025-JYB-JBGS-004) (2025-JYB-JBGS-004)

北京中医药大学东直门医院科技创新专项(DZMKJCX-2020-027) (DZMKJCX-2020-027)

首都卫生发展科研专项(首发2020-2-4192). (首发2020-2-4192)

天津中医药

1672-1519

访问量0
|
下载量0
段落导航相关论文